Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer
NCT03310632Phase 2Completed
- Sponsor
- Golden Biotechnology Corporation
- Start
- Dec 2017
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of antroquinonol in pancreatic cancer (PC), sponsored by Golden Biotechnology Corporation. Started Dec 2017; status: completed.
02
Drugs
antroquinonol
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT03310632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03310632.